DDX41 and infection: The preferential Ab targeting of S2 epitopes after infection may be partly attributed to a heterologous boost toward cross-reactive S2-specific memory B cells (56–58), with preexisting cross-reactive HCoV memory B cells activated during SARS-CoV-2 infection kick-starting production of anti-S2 Abs.